{"recordsFiltered":49224,"recordsTotal":49224,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=title&start=44400","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=title&start=43800","results":[{"registry_id":"NCT07353918","publication_url":"https://clinicaltrials.gov/study/NCT07353918","title":"Neuromodulation Using Low-intensity Focused Ultrasound for Potential Treatment for Medically Refractory Temporal Lobe Epilepsy","has_exemption":false,"start_date":"2025-10-13","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07188090","publication_url":"https://clinicaltrials.gov/study/NCT07188090","title":"A Prospective Trial Evaluating Plerixafor-based Mobilization and Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2025-10-16","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116838","publication_url":"https://clinicaltrials.gov/study/NCT06116838","title":"Effect of Varying Transcutaneous Spinal Cord Stimulation Parameters and Location on Lower Extremity Motor Responses and Comfort","has_exemption":false,"start_date":"2025-10-20","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810934","publication_url":"https://clinicaltrials.gov/study/NCT06810934","title":"A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses","has_exemption":false,"start_date":"2025-10-21","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Kara Chew","sponsor_slug":"kara-chew","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07194265","publication_url":"https://clinicaltrials.gov/study/NCT07194265","title":"A Prospective Randomized Trial Assessing the Safety and Effectiveness of the DurAVR® Biomimetic Valve Designed for Physiologic Flow Compared to Commercial TAVR Devices","has_exemption":false,"start_date":"2025-10-21","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Anteris Technologies Ltd.","sponsor_slug":"anteris-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06631638","publication_url":"https://clinicaltrials.gov/study/NCT06631638","title":"Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Non-Invasive Navigation","has_exemption":false,"start_date":"2025-10-24","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"DePuy Orthopaedics","sponsor_slug":"depuy-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06992258","publication_url":"https://clinicaltrials.gov/study/NCT06992258","title":"A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2025-10-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Criterium, Inc.","sponsor_slug":"criterium-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07575230","publication_url":"https://clinicaltrials.gov/study/NCT07575230","title":"Non-Opioid Pain Management After Mohs Reconstruction: An Investigator-Initiated, Prospective, Randomized Clinical Trial of Suzetrigine vs Hydrocodone/Acetaminophen","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820957","publication_url":"https://clinicaltrials.gov/study/NCT06820957","title":"Randomized Phase 2/3 Trial of Vincristine-Irinotecan-Regorafenib in Combination With Vincristine-Doxorubicin-Cyclophosphamide (VDC) and Ifosfamide-Etoposide (IE) in Patients With Newly Diagnosed Metastatic Ewing Sarcoma","has_exemption":false,"start_date":"2025-11-10","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07154693","publication_url":"https://clinicaltrials.gov/study/NCT07154693","title":"Wound Healing Following Tooth Extraction and Ridge Preservation Using Resorbable Non-ceramic Calcium Apatite Granules in Type I Bovine Collagen Plugs (OsteoGen®)","has_exemption":false,"start_date":"2025-11-19","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07189065","publication_url":"https://clinicaltrials.gov/study/NCT07189065","title":"An Open-Label, Randomized Controlled, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of Rocbrutinib Monotherapy Versus Investigator's Choice of Therapy in Patients With Relapsed or Refractory Non-GCB Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2025-11-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Lupeng Pharmaceutical Company LTD.","sponsor_slug":"guangzhou-lupeng-pharmaceutical-company-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296484","publication_url":"https://clinicaltrials.gov/study/NCT07296484","title":"Clofutriben And Placebo Phase 2 Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)","has_exemption":false,"start_date":"2025-11-29","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Sparrow Pharmaceuticals","sponsor_slug":"sparrow-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221721","publication_url":"https://clinicaltrials.gov/study/NCT07221721","title":"A Pilot Study to Assess the Feasibility and Safety of Targeting Mean Arterial Pressure to Reduce Intra-operative Hypotension","has_exemption":false,"start_date":"2025-11-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Bradley Marino","sponsor_slug":"bradley-marino","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225244","publication_url":"https://clinicaltrials.gov/study/NCT07225244","title":"Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction","has_exemption":false,"start_date":"2025-11-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"National Taiwan University Hospital","sponsor_slug":"national-taiwan-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06771830","publication_url":"https://clinicaltrials.gov/study/NCT06771830","title":"A Rapid Diagnostic of Risk in Hospitalized Pediatric Patients to Improve Outcomes Using Machine Learning","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07137104","publication_url":"https://clinicaltrials.gov/study/NCT07137104","title":"A Phase I/IIa Study to Investigate the Safety, Tolerability, and Preliminary Effectiveness of HeXell-2020 in Patients With Stable Coronary Artery Disease (CAD)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Hexun Biosciences Co., LTD.","sponsor_slug":"hexun-biosciences-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07249931","publication_url":"https://clinicaltrials.gov/study/NCT07249931","title":"Efficacy and Safety of Nerivio for the Management of Amplified Musculoskeletal Pain Syndrome in Pediatric Patients: A Nurse Practitioner-Led Pilot Study","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Health","sponsor_slug":"childrens-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174687","publication_url":"https://clinicaltrials.gov/study/NCT07174687","title":"Efficacy of Dapagliflozin in the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-12-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06666608","publication_url":"https://clinicaltrials.gov/study/NCT06666608","title":"The Efficacy of Bone Stimulator in Treatment and Return-to-Sport for Spondylolysis","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283835","publication_url":"https://clinicaltrials.gov/study/NCT07283835","title":"A Single-arm, Open-label, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of Cretostimogene Grenadenorepvec in Patients With BCG-unresponsive High-risk Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2025-12-04","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Lepu Biopharma Co., Ltd.","sponsor_slug":"lepu-biopharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04792034","publication_url":"https://clinicaltrials.gov/study/NCT04792034","title":"An Open-label, Two-Arm, Pharmacokinetics, Safety, and Tolerability Study of a Single Topical Dose of GOPRELTO® Nasal Solution and a Single Dose of NUMBRINO™ Nasal Solution for the Induction of Local Anesthesia of the Mucous Membranes When Performing Diagnostic Procedures and Surgeries in Pediatric Subjects From ≥12 Years to <18 Years of Age","has_exemption":false,"start_date":"2025-12-06","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Noden Pharma","sponsor_slug":"noden-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06946550","publication_url":"https://clinicaltrials.gov/study/NCT06946550","title":"1470 nm Non-Ablative Laser for the Treatment of Scarring Alopecia: A Clinical and Mechanistic Study","has_exemption":false,"start_date":"2025-12-09","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007559","publication_url":"https://clinicaltrials.gov/study/NCT07007559","title":"Protocol ASPEN-09-03: A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Participants With Metastatic HER2-Positive Breast Cancer, a Substudy Under Master Protocol ASPEN-09: A Phase 1b/2, Multicenter, Multi Arm Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies","has_exemption":false,"start_date":"2025-12-10","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"ALX Oncology Inc.","sponsor_slug":"alx-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07322094","publication_url":"https://clinicaltrials.gov/study/NCT07322094","title":"CATALINA-4: Phase 1B/2 Study of TORL-1-23 With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Newly Diagnosed Patients With Advanced Stage Ovarian Cancer","has_exemption":false,"start_date":"2025-12-10","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"TORL Biotherapeutics, LLC","sponsor_slug":"torl-biotherapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217717","publication_url":"https://clinicaltrials.gov/study/NCT07217717","title":"A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [¹⁸F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults With Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2025-12-11","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"SOFIE","sponsor_slug":"sofie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215845","publication_url":"https://clinicaltrials.gov/study/NCT07215845","title":"Pars Healing on oZTEo MRI","has_exemption":false,"start_date":"2025-12-12","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280260","publication_url":"https://clinicaltrials.gov/study/NCT07280260","title":"Effects of Early Loading Protocol on the Survival of the Nobel N1 Implant System: A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Louisiana State University Health Sciences Center in New Orleans","sponsor_slug":"louisiana-state-university-health-sciences-center-in-new-orleans","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280156","publication_url":"https://clinicaltrials.gov/study/NCT07280156","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Efficacy, Safety, and Dosing Regimen Selection of Multiple Intravenous Infusions of PRX-115 With and Without Methotrexate Versus Placebo in Adult Patients With Gout (RELEASE)","has_exemption":false,"start_date":"2025-12-22","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Protalix","sponsor_slug":"protalix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447050","publication_url":"https://clinicaltrials.gov/study/NCT07447050","title":"RiluzolE FOr Preventing Cognitive DysfUnction in Cancer PatientS Receiving Chemotherapy (REFOCUS)","has_exemption":false,"start_date":"2025-12-23","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07386340","publication_url":"https://clinicaltrials.gov/study/NCT07386340","title":"Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Senseonics, Inc.","sponsor_slug":"senseonics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07264894","publication_url":"https://clinicaltrials.gov/study/NCT07264894","title":"ZSDT for the Treatment of Recurrent Refractory Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Zhengzhou University","sponsor_slug":"zhengzhou-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282678","publication_url":"https://clinicaltrials.gov/study/NCT07282678","title":"Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder: Double-Blind, Controlled Randomized Multicenter Clinical Trial","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Pulvinar Neuro, LLC","sponsor_slug":"pulvinar-neuro-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06895889","publication_url":"https://clinicaltrials.gov/study/NCT06895889","title":"A Prospective, Randomized, Controlled, Open-label, First-in-human Phase I/IIb Study to Evaluate the Safety and Efficacy of the EB-OC Graft in the Repair of Full Thickness Chondral/osteochondral Defects of the Knee","has_exemption":false,"start_date":"2026-01-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Epibone, Inc.","sponsor_slug":"epibone-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07180576","publication_url":"https://clinicaltrials.gov/study/NCT07180576","title":"The FORCE Trial Pilot","has_exemption":false,"start_date":"2026-01-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Anna Arthur, PhD","sponsor_slug":"anna-arthur-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513493","publication_url":"https://clinicaltrials.gov/study/NCT07513493","title":"The Conventional Pipelle vs the Curved Aspirator Device: a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-01-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Maimonides Medical Center","sponsor_slug":"maimonides-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07476560","publication_url":"https://clinicaltrials.gov/study/NCT07476560","title":"Mesh Matters: Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment - a Randomized, Blinded Multicenter Study","has_exemption":false,"start_date":"2026-01-05","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Regionshospital Nordjylland","sponsor_slug":"regionshospital-nordjylland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06904261","publication_url":"https://clinicaltrials.gov/study/NCT06904261","title":"An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12 Month Treatment With Migalastat in Pediatric Subjects (Aged 2 to < 12 Years) With Fabry Disease and Amenable GLA Variants","has_exemption":false,"start_date":"2026-01-08","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Amicus Therapeutics","sponsor_slug":"amicus-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07158775","publication_url":"https://clinicaltrials.gov/study/NCT07158775","title":"A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP (AAV2-CAGChronosFP) in Patients With Geographic Atrophy Secondary to Dry AMD","has_exemption":false,"start_date":"2026-01-08","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Bionic Sight LLC","sponsor_slug":"bionic-sight-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219576","publication_url":"https://clinicaltrials.gov/study/NCT07219576","title":"PRISM: Phase 1b of Retifanlimab and Ruxolitinib In Solid Malignancies Progressing on Prior Checkpoint Inhibition","has_exemption":false,"start_date":"2026-01-08","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07089121","publication_url":"https://clinicaltrials.gov/study/NCT07089121","title":"Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis","has_exemption":false,"start_date":"2026-01-14","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Cartesian Therapeutics","sponsor_slug":"cartesian-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07196462","publication_url":"https://clinicaltrials.gov/study/NCT07196462","title":"Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07418112","publication_url":"https://clinicaltrials.gov/study/NCT07418112","title":"Comparing the Efficacy and Safety of Holmium Laser Lithotripsy Versus Electrohydraulic Lithotripsy for the Treatment of Difficult Choledocholithiasis and Pancreatic Duct Stones: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225621","publication_url":"https://clinicaltrials.gov/study/NCT07225621","title":"Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Standard of Care Adjuvant Temozolomide With or Without 5-Aminolevulinic Acid (5-ALA) With Concomitant Low Intensity Diffuse Ultrasound (LIDU) Sonodynamic Therapy (SDT) System In Patients With Newly Diagnosed Glioblastoma After Completion of Chemoradiotherapy","has_exemption":false,"start_date":"2026-01-28","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Alpheus Medical, Inc.","sponsor_slug":"alpheus-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07323654","publication_url":"https://clinicaltrials.gov/study/NCT07323654","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study Investigating the Efficacy and Safety Profile of KT-621 Administered Orally to Adult Participants With Uncontrolled Moderate to Severe Eosinophilic Asthma","has_exemption":false,"start_date":"2026-01-28","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Kymera Therapeutics, Inc.","sponsor_slug":"kymera-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290790","publication_url":"https://clinicaltrials.gov/study/NCT07290790","title":"A Prospective, Multicenter, Randomized, Post-market Clinical Investigation to Assess the Accuracy of Different Tooth Movements for Patients Undergoing Clear Aligner Therapy (CAT) With SureSmile® Clear Aligners With Three Different Trimlines.","has_exemption":false,"start_date":"2026-01-29","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Dentsply Sirona Implants and Consumables","sponsor_slug":"dentsply-sirona-implants-and-consumables","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07415941","publication_url":"https://clinicaltrials.gov/study/NCT07415941","title":"Home-based Mindfulness-based Meditation and Transcutaneous Auricular Vagus Nerve Stimulation for Older Adults With Low Back Pain and Depressive Symptoms","has_exemption":false,"start_date":"2026-01-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06950281","publication_url":"https://clinicaltrials.gov/study/NCT06950281","title":"Low Sodium Oxybate Use for Nocturnal Cluster Headache: Safety, Efficacy and Tolerability of JZP-258 (XYWAV) - a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Bi-center Study.","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Leiden University Medical Center","sponsor_slug":"leiden-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335510","publication_url":"https://clinicaltrials.gov/study/NCT07335510","title":"Impact of Barostimulation in Cardiac Hemodynamics and Clinical Outcomes Through Use of the Barostim™ CVRx Device","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06779617","publication_url":"https://clinicaltrials.gov/study/NCT06779617","title":"Full Title: Sepsis Early Prediction System Score (SEPSys Score) and RESCUE Score Multi-Site, Two-Intervention, Cluster-Randomized, Factorial Stepped-Wedge Pragmatic Clinical Trial at the University of Mayland Medical System","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226089","publication_url":"https://clinicaltrials.gov/study/NCT07226089","title":"Multicenter Interventional Study: Somatrogon Impact on Outcomes in Naive Small for Gestational Age or Idiopathic Short Stature Pediatric Patients Compared With Daily Growth Hormone","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Rabin Medical Center","sponsor_slug":"rabin-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07426120","publication_url":"https://clinicaltrials.gov/study/NCT07426120","title":"A Double-blind, Randomized, Placebo-controlled, Parallel-controlled, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Botanical Total Coumarin Cream (TC Cream) in Treating Patients With Psoriasis Vulgaris","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Psoriasis Research Institute of Guangzhou","sponsor_slug":"psoriasis-research-institute-of-guangzhou","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07348640","publication_url":"https://clinicaltrials.gov/study/NCT07348640","title":"A Prospective, Multi-National, Randomized, Double-Blind, Crossover Study to Evaluate the Efficacy and Safety of Gadopiclenol-enhanced MRA Compared to Gadoterate Meglumine-enhanced MRA in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease","has_exemption":false,"start_date":"2026-02-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Guerbet","sponsor_slug":"guerbet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07250750","publication_url":"https://clinicaltrials.gov/study/NCT07250750","title":"A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate A) the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of IM-101 in Adult Participants With Generalized Myasthenia Gravis, and B) the Efficacy and Safety of Treatment of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis","has_exemption":false,"start_date":"2026-02-05","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"ImmunAbs Inc.","sponsor_slug":"immunabs-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07195071","publication_url":"https://clinicaltrials.gov/study/NCT07195071","title":"Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening","has_exemption":false,"start_date":"2026-02-12","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07189871","publication_url":"https://clinicaltrials.gov/study/NCT07189871","title":"A Phase 1/2a Study of the Safety, Tolerability, and Preliminary Clinical Activity of 177LuBetaBart, a 177Lu-Labeled Anti-B7-H3 Monoclonal Antibody, in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Radiopharm Theranostics, Ltd","sponsor_slug":"radiopharm-theranostics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07500012","publication_url":"https://clinicaltrials.gov/study/NCT07500012","title":"Home-based Pain and Symptom Management for Breast Cancer Survivors: a Triple- Blinded RCT Pilot Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)","has_exemption":false,"start_date":"2026-02-24","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06502691","publication_url":"https://clinicaltrials.gov/study/NCT06502691","title":"[18F]FTT Positron Emission Tomography (PET) in Patients With Metastatic Breast Cancer","has_exemption":false,"start_date":"2026-02-26","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07474519","publication_url":"https://clinicaltrials.gov/study/NCT07474519","title":"An Assessment of Patient Position and Intravesical BCG Dwell Time","has_exemption":false,"start_date":"2026-02-26","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07139405","publication_url":"https://clinicaltrials.gov/study/NCT07139405","title":"A DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE II TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND SUPERIORITY OF TRIGLYTZA® OVER METFORMIN IN PATIENTS WITH INADEQUATE GLYCEMIC CONTROL OVER 24 WEEKS OF TREATMENT","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Myopharm Limited","sponsor_slug":"myopharm-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07388355","publication_url":"https://clinicaltrials.gov/study/NCT07388355","title":"WearLinq eWave Patch Study","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Wearlinq","sponsor_slug":"wearlinq","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221708","publication_url":"https://clinicaltrials.gov/study/NCT07221708","title":"Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin in Patients Treated With Systemic Antibiotic Therapy in a Community Hospital","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325591","publication_url":"https://clinicaltrials.gov/study/NCT07325591","title":"A Phase 2B/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tazbentetol in Participants With Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Spinogenix","sponsor_slug":"spinogenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07437339","publication_url":"https://clinicaltrials.gov/study/NCT07437339","title":"Volume Reduction for Open Fracture Irrigation: A Randomized Prospective Feasibility Trial","has_exemption":false,"start_date":"2026-03-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214987","publication_url":"https://clinicaltrials.gov/study/NCT07214987","title":"A Phase 2 Study of Toripalimab in Combination With Cisplatin and Docetaxel (PDT) for Induction Therapy in CPS-Positive Locally Advanced Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2026-03-09","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342530","publication_url":"https://clinicaltrials.gov/study/NCT07342530","title":"Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry Guided Breathing Therapy","has_exemption":false,"start_date":"2026-03-09","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07337590","publication_url":"https://clinicaltrials.gov/study/NCT07337590","title":"Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar","has_exemption":false,"start_date":"2026-03-10","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Exero Medical Ltd.","sponsor_slug":"exero-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06863311","publication_url":"https://clinicaltrials.gov/study/NCT06863311","title":"EXACT: Randomized Phase II Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC","has_exemption":false,"start_date":"2026-03-13","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Karie Runcie","sponsor_slug":"karie-runcie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300943","publication_url":"https://clinicaltrials.gov/study/NCT07300943","title":"A Phase 1/2 Study of CLIO-8221 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-03-19","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Callio Therapeutics","sponsor_slug":"callio-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288216","publication_url":"https://clinicaltrials.gov/study/NCT07288216","title":"A Phase 2 Posology Study With Long-Term Extension in Participants With Well-Controlled Recurrent Pericarditis to Evaluate the Efficacy and Safety of Transition Regimens to KPL-387 Monotherapy From Standard Therapies","has_exemption":false,"start_date":"2026-03-25","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Kiniksa Pharmaceuticals International, plc","sponsor_slug":"kiniksa-pharmaceuticals-international-plc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07402473","publication_url":"https://clinicaltrials.gov/study/NCT07402473","title":"EUREKA Study: Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer Using ctDNA and HARPS Biomarker Assay","has_exemption":false,"start_date":"2026-03-26","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712914","publication_url":"https://clinicaltrials.gov/study/NCT06712914","title":"Rapid Non-Invasive Brain Stimulation for Hoarding Disorder","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219472","publication_url":"https://clinicaltrials.gov/study/NCT07219472","title":"A Randomized, Single-Blind, Sham-Controlled Study of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07057791","publication_url":"https://clinicaltrials.gov/study/NCT07057791","title":"Phase II Dose Optimization Study of Platinum/Etoposide Plus Ivonescimab (CEI) as First-Line Treatment of Extensive-Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-03-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"PrECOG, LLC.","sponsor_slug":"precog-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07241546","publication_url":"https://clinicaltrials.gov/study/NCT07241546","title":"A Randomized, Double-blind, Placebo-controlled Phase 2a Study of ARO-RAGE Inhalation Solution to Assess Efficacy on Small Airway Dysfunction in Allergen-induced Mild Asthma","has_exemption":false,"start_date":"2026-03-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Pharmaceuticals","sponsor_slug":"arrowhead-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301320","publication_url":"https://clinicaltrials.gov/study/NCT07301320","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Prospective, Investigator-Initiated Trial to Assess the Efficacy, Safety, and Pharmacokinetics of Epetraborole in Patients With Mycobacterium Abscessus Lung Disease: REBOUND Study","has_exemption":false,"start_date":"2026-03-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Kevin Winthrop","sponsor_slug":"kevin-winthrop","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05029336","publication_url":"https://clinicaltrials.gov/study/NCT05029336","title":"Autologous Hematopoietic Stem Cell Transplant for Children and Young Adults With Life Threatening Autoimmune Diseases","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Stephan Grupp MD PhD","sponsor_slug":"stephan-grupp-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103330","publication_url":"https://clinicaltrials.gov/study/NCT07103330","title":"Evaluation of Cranial Flap Fixation With Montage Flowable Settable Bone Paste","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Abyrx, Inc.","sponsor_slug":"abyrx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227233","publication_url":"https://clinicaltrials.gov/study/NCT07227233","title":"Artificial Intelligence and Machine Learning-Enhanced Biomarker-dRiven CDK4/6 Inhibitor Rechallenge in HR+ HER2- Advanced Breast Tumors.","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07340710","publication_url":"https://clinicaltrials.gov/study/NCT07340710","title":"Decreasing Edema With a Novel OCS Solution (DENOVO) Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"TransMedics","sponsor_slug":"transmedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07336472","publication_url":"https://clinicaltrials.gov/study/NCT07336472","title":"A Phase I/II, Multicenter, Open-label Study of IBI3003 in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Fortvita Biologics (USA)Inc.","sponsor_slug":"fortvita-biologics-usainc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369024","publication_url":"https://clinicaltrials.gov/study/NCT07369024","title":"Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults: A Randomized Control Trial","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Mohsen Saidinejad","sponsor_slug":"mohsen-saidinejad","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07412626","publication_url":"https://clinicaltrials.gov/study/NCT07412626","title":"HeartLogic Optimization of CHF Medications in Chronic Low EF Population: A Follow-on Study","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Robert Pickett","sponsor_slug":"robert-pickett","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07423585","publication_url":"https://clinicaltrials.gov/study/NCT07423585","title":"A Front-Line Window-of-Opportunity Phase 2 Study of Tarlatamab (Bispecific T Cell Engager: DLL3-CD3) in Patients With Extensive-Stage Small-Cell Lung Cancer","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Asrar Alahmadi","sponsor_slug":"asrar-alahmadi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07454915","publication_url":"https://clinicaltrials.gov/study/NCT07454915","title":"PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"PapiVax Biotech, Inc.","sponsor_slug":"papivax-biotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07561541","publication_url":"https://clinicaltrials.gov/study/NCT07561541","title":"Extended Oral Antibiotic Prophylaxis in Diabetic Patients With Lower Extremity Fracture: A Multicenter Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center, El Paso","sponsor_slug":"texas-tech-university-health-sciences-center-el-paso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07422831","publication_url":"https://clinicaltrials.gov/study/NCT07422831","title":"Improving Type 2 Diabetes Management in Primary Care Through Periodic Continuous Glucose Monitoring","has_exemption":false,"start_date":"2026-04-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07434128","publication_url":"https://clinicaltrials.gov/study/NCT07434128","title":"Progesterone Receptor Modulator Mammogram Pretreatment for Premenopausal People With a History of Extremely Dense Breast Tissue","has_exemption":false,"start_date":"2026-04-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07456696","publication_url":"https://clinicaltrials.gov/study/NCT07456696","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD","has_exemption":false,"start_date":"2026-04-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Transcend Therapeutics","sponsor_slug":"transcend-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540221","publication_url":"https://clinicaltrials.gov/study/NCT07540221","title":"An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","has_exemption":false,"start_date":"2026-04-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07417943","publication_url":"https://clinicaltrials.gov/study/NCT07417943","title":"Noninvasive Spinal Cord Neuromodulation to Enhance Motor Function in Individuals With Hereditary Spastic Paraplegia","has_exemption":false,"start_date":"2026-04-09","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Rahul Sachdeva","sponsor_slug":"rahul-sachdeva","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06930352","publication_url":"https://clinicaltrials.gov/study/NCT06930352","title":"Frontline Ziftomenib in NPM1-Mutated or KMT2A-Rearranged Acute Myeloid Leukemia in Patients Not Eligible for Intensive Induction or Other Therapy","has_exemption":false,"start_date":"2026-04-10","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Uma Borate","sponsor_slug":"uma-borate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210515","publication_url":"https://clinicaltrials.gov/study/NCT07210515","title":"A Randomized, Triple-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous AMBTX-01 (Neridronate) for Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-RISE)","has_exemption":false,"start_date":"2026-04-14","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ambros Therapeutics, Inc.","sponsor_slug":"ambros-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217990","publication_url":"https://clinicaltrials.gov/study/NCT07217990","title":"Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer","has_exemption":false,"start_date":"2026-04-15","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07343596","publication_url":"https://clinicaltrials.gov/study/NCT07343596","title":"Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery","has_exemption":false,"start_date":"2026-04-15","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06796504","publication_url":"https://clinicaltrials.gov/study/NCT06796504","title":"The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study","has_exemption":false,"start_date":"2026-04-17","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"SetPoint Medical Corporation","sponsor_slug":"setpoint-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565428","publication_url":"https://clinicaltrials.gov/study/NCT07565428","title":"A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Monotherapy Study to Evaluate Efficacy of Roluperidone on Negative Symptoms in Adult Subjects With Schizophrenia, Followed by a 40-Week, Randomized, Double-Dummy Phase to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications","has_exemption":false,"start_date":"2026-04-23","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Minerva Neurosciences","sponsor_slug":"minerva-neurosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225777","publication_url":"https://clinicaltrials.gov/study/NCT07225777","title":"Sex Differences in Neurobehavioral Response to Acute THC in Adults With Cannabis Use Disorder","has_exemption":false,"start_date":"2026-04-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07506876","publication_url":"https://clinicaltrials.gov/study/NCT07506876","title":"Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer","has_exemption":false,"start_date":"2026-04-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Legacy Health System","sponsor_slug":"legacy-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948552","publication_url":"https://clinicaltrials.gov/study/NCT06948552","title":"A Phase II Study on Photodynamic Diagnosis of Urological Cancer in the Upper Urinary Tract Using Fluorescence Endoscopy With Cystoscopy and Ureteroscopy With 5-ALA","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07359807","publication_url":"https://clinicaltrials.gov/study/NCT07359807","title":"MAGICTouchTM PTA Sirolimus-Coated BALloon vs Paclitaxel Coated Balloon for Treatment of High-grade Stenotic or Occluded Lesions in Femoro-Popliteal Arteries","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Concept Medical Inc.","sponsor_slug":"concept-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477366","publication_url":"https://clinicaltrials.gov/study/NCT07477366","title":"Open-Label, Phase 2 Chemotherapy-Free Study of CD19 t-haNK and NAI in Combination With Rituximab in Participants With Relapsed/Refractory B-Cell Indolent Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07524946","publication_url":"https://clinicaltrials.gov/study/NCT07524946","title":"A 12-Week, Phase 4, Open-Label Study To Assess Safety, Pharmacokinetics, and Treatment Effect of CABTREO (Clindamycin Phosphate 1.2%, Adapalene 0.15%, and Benzoyl Peroxide 3.1%) Topical Gel In Pediatric Participants Ages 9 to 11 Years, 11 Month With Acne Vulgaris","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07508124","publication_url":"https://clinicaltrials.gov/study/NCT07508124","title":"Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants With a First Febrile Urinary Tract Infection: a Multi-center Pilot Study","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07536399","publication_url":"https://clinicaltrials.gov/study/NCT07536399","title":"Biologic Augmentation of Temporomandibular Joint Arthroscopy Using Bone Marrow Aspirate Concentrate (BMAC): A Proposed Clinical Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07524465","publication_url":"https://clinicaltrials.gov/study/NCT07524465","title":"Investigator-led Observational Clinical Research Project Evaluating the Impact of the ReFeel for Digital Nerve Injuries.","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"OrthoCarolina Research Institute, Inc.","sponsor_slug":"orthocarolina-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07557056","publication_url":"https://clinicaltrials.gov/study/NCT07557056","title":"A Phase 2 Study of Nemtabrutinib and Venetoclax as Frontline Treatment for Chronic Lymphocytic Leukemia (CLL)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Jennifer Woyach","sponsor_slug":"jennifer-woyach","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07529483","publication_url":"https://clinicaltrials.gov/study/NCT07529483","title":"Endoscopic Ultrasound-Guided Chemoablation of Pancreatic Cysts - An Efficacy Trial","has_exemption":false,"start_date":"2026-05-12","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948214","publication_url":"https://clinicaltrials.gov/study/NCT06948214","title":"A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)","has_exemption":false,"start_date":"2026-05-20","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Lumos Pharma","sponsor_slug":"lumos-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079826","publication_url":"https://clinicaltrials.gov/study/NCT07079826","title":"Sparrow Link Device for Opioid Withdrawal Management at UPMC Presbyterian With the Substance Treatment and Recovery Service (STARS; Formerly Addiction Medicine Consult Service)","has_exemption":false,"start_date":"2026-05-27","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Payel Roy","sponsor_slug":"payel-roy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07623668","publication_url":"https://clinicaltrials.gov/study/NCT07623668","title":"A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)","has_exemption":false,"start_date":"2026-05-28","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Oculis","sponsor_slug":"oculis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07627971","publication_url":"https://clinicaltrials.gov/study/NCT07627971","title":"A Phase 1/2, Open-label, Single Dose Study of SKY-GJB2 Given as a Single Unilateral Intracochlear Administration in Pediatric Subjects With GJB2-mediated Hearing Loss","has_exemption":false,"start_date":"2026-05-28","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Skylark Bio Inc.","sponsor_slug":"skylark-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553494","publication_url":"https://clinicaltrials.gov/study/NCT07553494","title":"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of SLN12140 in Adult Patients With Primary IgA Nephropathy","has_exemption":false,"start_date":"2026-05-29","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Linno Pharmaceuticals, Inc.","sponsor_slug":"linno-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216001","publication_url":"https://clinicaltrials.gov/study/NCT07216001","title":"Role of Omega-DEK in Childhood Apraxia of Speech","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Claudia R. Morris","sponsor_slug":"claudia-r-morris","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07318623","publication_url":"https://clinicaltrials.gov/study/NCT07318623","title":"Comparative Evaluation of Treatment Outcomes Between Damon Ultima and Pitts 21 Pro Bracket Systems; A Randomized Clinical Trial","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Baghdad","sponsor_slug":"university-of-baghdad","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07594483","publication_url":"https://clinicaltrials.gov/study/NCT07594483","title":"Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Motif Neurotech, Inc.","sponsor_slug":"motif-neurotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592468","publication_url":"https://clinicaltrials.gov/study/NCT07592468","title":"Intraoperative Fractionated CO₂ Laser Treatment of Wound Edges During Mohs Micrographic Surgery","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288593","publication_url":"https://clinicaltrials.gov/study/NCT07288593","title":"Insomnia, Nightmares, and Sympathetic Hyperactivity Intervention in the warfiGHTer (INSIGHT)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Uniformed Services University of the Health Sciences","sponsor_slug":"uniformed-services-university-of-the-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07528157","publication_url":"https://clinicaltrials.gov/study/NCT07528157","title":"Early TMS-EEG Potentials as Biomarkers for Personalized Neuromodulation in Treatment-Resistant Depression (R61 Phase)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07569926","publication_url":"https://clinicaltrials.gov/study/NCT07569926","title":"The Impact of Fluciclovine (18F) PET on the Management of Participants With Prostate Cancer Following Negative or Equivocal PSMA PET Imaging at the Time of Biochemical Recurrence","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Blue Earth Diagnostics","sponsor_slug":"blue-earth-diagnostics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07519902","publication_url":"https://clinicaltrials.gov/study/NCT07519902","title":"Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED)","has_exemption":false,"start_date":"2026-06-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06622057","publication_url":"https://clinicaltrials.gov/study/NCT06622057","title":"Phase III, Randomized, Double-blind Study of Combination Therapy With D07001-Softgel Capsules and Capecitabine vs Placebo and Capecitabine in Patients With Advanced BTC After Failed on Gemcitabine, Platin, and FOLFOX or Irinotecan Regimens","has_exemption":false,"start_date":"2026-06-09","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"InnoPharmax Inc.","sponsor_slug":"innopharmax-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104032","publication_url":"https://clinicaltrials.gov/study/NCT07104032","title":"A Phase 3, Multi-regional, Open-label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Participants With Relapsed/Refractory Primary Central Nervous System Lymphoma","has_exemption":false,"start_date":"2026-06-12","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ono Pharmaceutical Co. Ltd","sponsor_slug":"ono-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07463820","publication_url":"https://clinicaltrials.gov/study/NCT07463820","title":"A Phase II Study of Combination Therapy With Luspatercept in Lower Risk Myelodysplasia: A Tier 1 MyeloMATCH Substudy","has_exemption":false,"start_date":"2026-06-19","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05423197","publication_url":"https://clinicaltrials.gov/study/NCT05423197","title":"Phase II Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05545891","publication_url":"https://clinicaltrials.gov/study/NCT05545891","title":"A Double-Blind, Placebo Controlled Study of Aripiprazole in Body Focused Repetitive Behaviors","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06536374","publication_url":"https://clinicaltrials.gov/study/NCT06536374","title":"A Phase II, Open Label, Randomized Controlled Pilot Study Evaluating Trimethoprim in Patients Commencing Androgen Deprivation Therapy for Prostate Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07019610","publication_url":"https://clinicaltrials.gov/study/NCT07019610","title":"Evaluation of Chlorhexidine Caps for Central Line Associated Blood Stream Infection Prevention in People Needing Hemodialysis: a Pilot Randomised Control Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Queensland","sponsor_slug":"the-university-of-queensland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111988","publication_url":"https://clinicaltrials.gov/study/NCT07111988","title":"Valbenazine in Obsessive-compulsive Disorder: A Randomized Double-blind Placebo-controlled Crossover Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369128","publication_url":"https://clinicaltrials.gov/study/NCT07369128","title":"A Randomized, Dose-Ranging Trial of Propofol-Only and Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07430228","publication_url":"https://clinicaltrials.gov/study/NCT07430228","title":"Efficacy of Intravenous Oxytocin to Speed Recovery After Total Hip Arthroplasty","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07503236","publication_url":"https://clinicaltrials.gov/study/NCT07503236","title":"ENHANCE EFS: Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Nyra Medical, Inc.","sponsor_slug":"nyra-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565909","publication_url":"https://clinicaltrials.gov/study/NCT07565909","title":"A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07576881","publication_url":"https://clinicaltrials.gov/study/NCT07576881","title":"Impact of Standardization on Outcomes Following Cervical Ripening","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07577336","publication_url":"https://clinicaltrials.gov/study/NCT07577336","title":"Ultralow-Field Portable MRI for Detection of Pediatric Hypoxic Ischemic Brain Injury","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07587749","publication_url":"https://clinicaltrials.gov/study/NCT07587749","title":"Skin Substitutes Versus Secondary Intention Healing After Mohs Micrographic Surgery","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07601425","publication_url":"https://clinicaltrials.gov/study/NCT07601425","title":"A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Atavistik Bio, Inc","sponsor_slug":"atavistik-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07620561","publication_url":"https://clinicaltrials.gov/study/NCT07620561","title":"Evaluating the Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients: A 24-Week Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07643766","publication_url":"https://clinicaltrials.gov/study/NCT07643766","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Enveda Therapeutics","sponsor_slug":"enveda-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820281","publication_url":"https://clinicaltrials.gov/study/NCT06820281","title":"Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes: a Phase 2 Double Blinded Placebo Controlled Clinical Trial (TIRTLE2)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Victor Chang Cardiac Research Institute","sponsor_slug":"victor-chang-cardiac-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06905912","publication_url":"https://clinicaltrials.gov/study/NCT06905912","title":"Comparison Between FL41 Tinted Spectacles, Biomedics55 Premier Contact Lenses, and Altius Tinted Contact Lenses on Photophobia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301424","publication_url":"https://clinicaltrials.gov/study/NCT07301424","title":"Phase II Study of Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL Positive B-Cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07336381","publication_url":"https://clinicaltrials.gov/study/NCT07336381","title":"An Exploratory Clinical Study Using the Replexa+ Device in Veterans With Lower Extremity Peripheral Artery Disease Experiencing Peripheral Neuropathy","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07503925","publication_url":"https://clinicaltrials.gov/study/NCT07503925","title":"THRIVE Study: Informing Oral Nicotine Pouch Regulations to Promote Public Health","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570537","publication_url":"https://clinicaltrials.gov/study/NCT07570537","title":"TubeClear System Evaluation in Pediatric Patients","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571018","publication_url":"https://clinicaltrials.gov/study/NCT07571018","title":"Development and Pilot Evaluation of a Novel Mobile Health Intervention for Young Adult Tobacco Cessation","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07569822","publication_url":"https://clinicaltrials.gov/study/NCT07569822","title":"Effect of Vibrator Use on Symptoms of Urgency Urinary Incontinence, Sexual Function, and Sleep","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07630896","publication_url":"https://clinicaltrials.gov/study/NCT07630896","title":"Postoperative Prednisone Regimen in TKA and Its Effect on Continuous Glucose Levels","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07594678","publication_url":"https://clinicaltrials.gov/study/NCT07594678","title":"A Pilot Study of Low-Level Red-Light Therapy Combined With Topical Minoxidil Compared With Topical Minoxidil Alone in Breast Cancer Patients With Chemotherapy-Induced Alopecia","has_exemption":false,"start_date":"2026-07-02","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07589634","publication_url":"https://clinicaltrials.gov/study/NCT07589634","title":"79635322MMY2002: Phase 2 Randomized, Double-blind, Placebo-controlled Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2026-07-20","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05792020","publication_url":"https://clinicaltrials.gov/study/NCT05792020","title":"Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound (fUS) Over the Motor Cortex","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05847179","publication_url":"https://clinicaltrials.gov/study/NCT05847179","title":"A Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin for the Treatment of Bone Mineral Density (BMD) Loss in Subjects With Typical Werner Syndrome","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"PRG Science & Technology Co., Ltd.","sponsor_slug":"prg-science-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07077746","publication_url":"https://clinicaltrials.gov/study/NCT07077746","title":"A Randomized, Double-Blind, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Crohn's Disease","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Hope Biosciences Research Foundation","sponsor_slug":"hope-biosciences-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07097311","publication_url":"https://clinicaltrials.gov/study/NCT07097311","title":"A Phase II, Open Label Study to Evaluate the Safety of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Jerry Vockley, MD, PhD","sponsor_slug":"jerry-vockley-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07133412","publication_url":"https://clinicaltrials.gov/study/NCT07133412","title":"An Evaluation of the Neuromuscular Junction in Infants Using Train-of-four Monitoring With the TetraGraph™ Neuromuscular Transmission Monitor","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Joseph D. Tobias","sponsor_slug":"joseph-d-tobias","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231965","publication_url":"https://clinicaltrials.gov/study/NCT07231965","title":"Effects Of Cannabis Products On Blood Pressure Control","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512128","publication_url":"https://clinicaltrials.gov/study/NCT07512128","title":"Prospective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral Stenting (SKYWARD Trans-Femoral IDE Study)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Shockwave Medical, Inc.","sponsor_slug":"shockwave-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06463678","publication_url":"https://clinicaltrials.gov/study/NCT06463678","title":"A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal Keratitis","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"IVIEW Therapeutics Inc.","sponsor_slug":"iview-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07604246","publication_url":"https://clinicaltrials.gov/study/NCT07604246","title":"Nicotine Effects on Eye Movements and Self-Report Measures (NICS-EYES)","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619417","publication_url":"https://clinicaltrials.gov/study/NCT07619417","title":"Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation of Pancreatic Neoplasms - A Safety and Feasibility Trial","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07657312","publication_url":"https://clinicaltrials.gov/study/NCT07657312","title":"Phase 2 Study of Cytokine Release Syndrome Prophylaxis With Infliximab for Teclistamab/Talquetamab Therapy in Patients With Relapsed/Refractory Myeloma","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Naresh Bumma","sponsor_slug":"naresh-bumma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07647068","publication_url":"https://clinicaltrials.gov/study/NCT07647068","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Unresectable, Recurrent, or Metastatic Gastrointestinal Stromal Tumors","has_exemption":false,"start_date":"2026-08-15","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Joal Beane","sponsor_slug":"joal-beane","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449313","publication_url":"https://clinicaltrials.gov/study/NCT06449313","title":"A Phase 2 Single-Arm Study of Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advance Non-Small Cell Lung Cancer (NSCLC) With N3 Lymph Node Involvement","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07644585","publication_url":"https://clinicaltrials.gov/study/NCT07644585","title":"A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"IBA Proton Therapy, Inc.","sponsor_slug":"iba-proton-therapy-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227103","publication_url":"https://clinicaltrials.gov/study/NCT07227103","title":"A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression: The MIND1 Trial","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"NeuroRx, Inc.","sponsor_slug":"neurorx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07629635","publication_url":"https://clinicaltrials.gov/study/NCT07629635","title":"Cessation of Migraine Headaches With Patent Foramen Ovale-Directed Therapy (COMFORT - PFO): An Investigator-Initiated Study","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07094906","publication_url":"https://clinicaltrials.gov/study/NCT07094906","title":"Neural and Vascular Modulation With Isometric Handgrip Training in Chronic Kidney Disease","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07640776","publication_url":"https://clinicaltrials.gov/study/NCT07640776","title":"Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Angiodynamics, Inc.","sponsor_slug":"angiodynamics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07616167","publication_url":"https://clinicaltrials.gov/study/NCT07616167","title":"From Stroke Rehabilitation to Independence: An Impairment-Aware Control Framework for Adaptive Exoskeleton Assistance","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06294821","publication_url":"https://clinicaltrials.gov/study/NCT06294821","title":"4-Aminopyridine to Delay Carpal Tunnel Release or Resolve Carpal Tunnel Syndrome","has_exemption":false,"start_date":"2026-11-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"John Elfar","sponsor_slug":"john-elfar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07618806","publication_url":"https://clinicaltrials.gov/study/NCT07618806","title":"A Prospective, Multicenter, Randomized, Double-Blind, Active-Controlled Phase IIIb Clinical Trial Evaluating the Incidence of Ankle Edema (Ankle Edema Volume) Induced by Levamlodipine Monotherapy vs Amlodipine in Treatment-Naïve or Mildly Uncontrolled Hypertensive Post-Menopausal Women.","has_exemption":false,"start_date":"2026-11-30","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Zentiva, k.s.","sponsor_slug":"zentiva-ks","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05764928","publication_url":"https://clinicaltrials.gov/study/NCT05764928","title":"A Phase I/II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404Oral Liquid Combined With Pemetrexed + Cisplatin Therapy in Patients With Advanced Inoperable or Metastatic EGFR Wild-type Non-Small Cell Lung Cancer Patients","has_exemption":false,"start_date":"2026-12-01","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Rgene Corporation","sponsor_slug":"rgene-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05039892","publication_url":"https://clinicaltrials.gov/study/NCT05039892","title":"An Open-label, Single Arm, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma With FGFR2 Gene Alterations","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"3D Medicines (Beijing) Co., Ltd.","sponsor_slug":"3d-medicines-beijing-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05077215","publication_url":"https://clinicaltrials.gov/study/NCT05077215","title":"A Phase 3, Randomized, Open-Label, Active-Controlled, Superiority Trial of EG007, Added to the Combination of Lenvatinib Plus Pembrolizumab vs. Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Evergreen Therapeutics, Inc.","sponsor_slug":"evergreen-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216170","publication_url":"https://clinicaltrials.gov/study/NCT07216170","title":"REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Microvention-Terumo, Inc.","sponsor_slug":"microvention-terumo-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512427","publication_url":"https://clinicaltrials.gov/study/NCT07512427","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of OPK-88006 in Healthy and Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) Participants","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"OPKO Health, Inc.","sponsor_slug":"opko-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06934928","publication_url":"https://clinicaltrials.gov/study/NCT06934928","title":"Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1 Associated Cutaneous Neurofibromas (cNFs)","has_exemption":false,"start_date":"2027-01-31","completion_date":"2027-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02407405","publication_url":"https://clinicaltrials.gov/study/NCT02407405","title":"Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas","has_exemption":false,"start_date":"2016-01-07","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03850366","publication_url":"https://clinicaltrials.gov/study/NCT03850366","title":"HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Following Fludarbine/Melphalan/Total Body Irradiation Conditioning Regimen","has_exemption":false,"start_date":"2016-03-08","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03475147","publication_url":"https://clinicaltrials.gov/study/NCT03475147","title":"Validation of a Smartphone-Based Flicker Fusion Test","has_exemption":false,"start_date":"2017-01-27","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Randy Kardon","sponsor_slug":"randy-kardon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03311503","publication_url":"https://clinicaltrials.gov/study/NCT03311503","title":"Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning","has_exemption":false,"start_date":"2018-02-26","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"David Williams","sponsor_slug":"david-williams","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03661307","publication_url":"https://clinicaltrials.gov/study/NCT03661307","title":"A Phase I/II Study of Quizartinib in Combination With Decitabine and Venetoclax for the Treatment of Patients With Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2018-10-31","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03475173","publication_url":"https://clinicaltrials.gov/study/NCT03475173","title":"New Non-invasive Modalities for Assessing Retinal Structure and Function:Preliminary Investigation","has_exemption":false,"start_date":"2019-05-06","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Randy Kardon","sponsor_slug":"randy-kardon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03694626","publication_url":"https://clinicaltrials.gov/study/NCT03694626","title":"Use of Facial Feature to Objectively Diagnose and Monitor Treatment of Light Sensitivity","has_exemption":false,"start_date":"2019-07-11","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Randy Kardon","sponsor_slug":"randy-kardon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03952637","publication_url":"https://clinicaltrials.gov/study/NCT03952637","title":"A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis","has_exemption":false,"start_date":"2019-08-19","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"National Human Genome Research Institute (NHGRI)","sponsor_slug":"national-human-genome-research-institute-nhgri","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04267887","publication_url":"https://clinicaltrials.gov/study/NCT04267887","title":"Advanced ChemoHormonal Therapy for Treatment Naïve Metastatic Prostate Cancer: Apalutamide and Abiraterone Acetate With Prednisone and Androgen Deprivation Therapy After Treatment With Docetaxel and Androgen Deprivation Therapy","has_exemption":false,"start_date":"2020-05-11","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05232253","publication_url":"https://clinicaltrials.gov/study/NCT05232253","title":"Measurement of Bladder Pressure With a Novel External Device (Cystoealstometer) - Home","has_exemption":false,"start_date":"2021-01-18","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05504499","publication_url":"https://clinicaltrials.gov/study/NCT05504499","title":"REFINE Study: A Prospective, Observational, Open-Label, Non-Randomized, Multi-Center Study Measuring Functional Outcomes In a Novel Interspinous Fusion Device In Subjects With Low Back Pain","has_exemption":false,"start_date":"2021-03-19","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Pacific Research Institute","sponsor_slug":"pacific-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04234971","publication_url":"https://clinicaltrials.gov/study/NCT04234971","title":"Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate: A Randomized Clinical Trial","has_exemption":false,"start_date":"2021-06-14","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03496883","publication_url":"https://clinicaltrials.gov/study/NCT03496883","title":"Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial","has_exemption":false,"start_date":"2021-12-03","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Joseph Broderick, MD","sponsor_slug":"joseph-broderick-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05332067","publication_url":"https://clinicaltrials.gov/study/NCT05332067","title":"Omalizumab Before Onset of Exacerbations","has_exemption":false,"start_date":"2022-05-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Children's National Research Institute","sponsor_slug":"childrens-national-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05556655","publication_url":"https://clinicaltrials.gov/study/NCT05556655","title":"Brain Stimulation Effects on Cognitive Task Performance","has_exemption":false,"start_date":"2023-04-20","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Colorado State University","sponsor_slug":"colorado-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05779423","publication_url":"https://clinicaltrials.gov/study/NCT05779423","title":"A Phase II Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Advanced Melanoma Receiving Post-progression Dual Immune Checkpoint Inhibitor Therapy","has_exemption":false,"start_date":"2023-09-23","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06176261","publication_url":"https://clinicaltrials.gov/study/NCT06176261","title":"DATO-BASE: A Phase 2 Trial of DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs","has_exemption":false,"start_date":"2024-01-08","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Sarah Sammons, MD","sponsor_slug":"sarah-sammons-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145035","publication_url":"https://clinicaltrials.gov/study/NCT06145035","title":"University of Louisville - 18642 / CATO Study, Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy","has_exemption":false,"start_date":"2024-03-04","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Roberto Bolli","sponsor_slug":"roberto-bolli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06094816","publication_url":"https://clinicaltrials.gov/study/NCT06094816","title":"Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study","has_exemption":false,"start_date":"2024-03-05","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Delaware","sponsor_slug":"university-of-delaware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06069726","publication_url":"https://clinicaltrials.gov/study/NCT06069726","title":"A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial","has_exemption":false,"start_date":"2024-03-21","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06845735","publication_url":"https://clinicaltrials.gov/study/NCT06845735","title":"Prospective Randomized Control Trial Comparing Absorbable Sutures to Non-Absorbable Sutures for Capsular Closures in Hip Arthroscopies","has_exemption":false,"start_date":"2024-03-22","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947500","publication_url":"https://clinicaltrials.gov/study/NCT05947500","title":"A Randomized Phase 2 Study of ATR Inhibition in Advanced PD-(L)1-Refractory Merkel Cell Carcinoma: The MATRiX Trial","has_exemption":false,"start_date":"2024-05-21","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06059391","publication_url":"https://clinicaltrials.gov/study/NCT06059391","title":"Placebo-Controlled and Randomized Phase 2 Trial of CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients After Hematopoietic Stem Cell Transplant","has_exemption":false,"start_date":"2024-07-12","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533826","publication_url":"https://clinicaltrials.gov/study/NCT06533826","title":"A Phase II Non-comparative Trial of Datopotamab Deruxtecan (Dato-DXd) or Trastuzumab Deruxtecan (T-DXd) in Patients With Metastatic HER2-negative (HER2-low or HER2-0) Breast Cancer After Progression on Prior Antibody Drug Conjugate Therapy","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Ana C Garrido-Castro, MD","sponsor_slug":"ana-c-garrido-castro-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06185816","publication_url":"https://clinicaltrials.gov/study/NCT06185816","title":"Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain","has_exemption":false,"start_date":"2024-11-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973512","publication_url":"https://clinicaltrials.gov/study/NCT06973512","title":"HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use Disorders","has_exemption":false,"start_date":"2024-11-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Centre for Addiction and Mental Health","sponsor_slug":"centre-for-addiction-and-mental-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06741969","publication_url":"https://clinicaltrials.gov/study/NCT06741969","title":"A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults With Moderate to Severe Sjogren's Disease (SjD)","has_exemption":false,"start_date":"2024-12-04","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06627673","publication_url":"https://clinicaltrials.gov/study/NCT06627673","title":"MultiCenter Prospective Parallel Registry Controlled Investigational Device Exemption Clinical Study to Determine Non-Inferiority of the PEEK-OPTIMA™ Femoral Component Versus a CoCr Alloy Femoral Component of Similar Design for TKA","has_exemption":false,"start_date":"2025-01-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Maxx Orthopedics Inc","sponsor_slug":"maxx-orthopedics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06286397","publication_url":"https://clinicaltrials.gov/study/NCT06286397","title":"Topical Anti-Androgens in Pilonidal Sinus Disease","has_exemption":false,"start_date":"2025-01-10","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06771622","publication_url":"https://clinicaltrials.gov/study/NCT06771622","title":"Phase Ib/IIa, Open-label, Multicenter, Dose Escalation, and Dose Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-03-13","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"FBD Biologics Limited","sponsor_slug":"fbd-biologics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06753916","publication_url":"https://clinicaltrials.gov/study/NCT06753916","title":"Multicenter Clinical Trial to Evaluate the Safety and Efficacy of Ex Vivo Corneal Cross-linking of Donor Corneal Tissue Used for Vascularized High-risk Keratoplasty","has_exemption":false,"start_date":"2025-04-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06355310","publication_url":"https://clinicaltrials.gov/study/NCT06355310","title":"Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease","has_exemption":false,"start_date":"2025-04-10","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Justin Ryder","sponsor_slug":"justin-ryder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630221","publication_url":"https://clinicaltrials.gov/study/NCT06630221","title":"A Phase II Study of Eltrombopag as a Novel Therapeutic Approach for Patients With Low-risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) With TET2 Mutations","has_exemption":false,"start_date":"2025-06-17","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Abhay Singh, MD MPH","sponsor_slug":"abhay-singh-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06901687","publication_url":"https://clinicaltrials.gov/study/NCT06901687","title":"Home-Based tDCS for Depression in Multiple Sclerosis: A Randomized Sham-Controlled Trial","has_exemption":false,"start_date":"2025-08-11","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049848","publication_url":"https://clinicaltrials.gov/study/NCT07049848","title":"SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma","has_exemption":false,"start_date":"2025-09-11","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07102381","publication_url":"https://clinicaltrials.gov/study/NCT07102381","title":"A Phase 2, Randomized, Multicenter, Open-label Neoadjuvant Study Evaluating Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer","has_exemption":false,"start_date":"2025-09-24","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885554","publication_url":"https://clinicaltrials.gov/study/NCT06885554","title":"Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation","has_exemption":false,"start_date":"2025-10-06","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146685","publication_url":"https://clinicaltrials.gov/study/NCT07146685","title":"Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study","has_exemption":false,"start_date":"2026-01-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07457489","publication_url":"https://clinicaltrials.gov/study/NCT07457489","title":"Vanderbilt Integrated Community TMS for Opioid Recovery","has_exemption":false,"start_date":"2026-01-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06707493","publication_url":"https://clinicaltrials.gov/study/NCT06707493","title":"A Randomized, Placebo-Controlled Phase 2 Study of IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation","has_exemption":false,"start_date":"2026-01-16","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07158021","publication_url":"https://clinicaltrials.gov/study/NCT07158021","title":"Phase 2 Randomized Trial to Examine Ovarian Function Suppression for Breast Cancer (OFS)","has_exemption":false,"start_date":"2026-01-22","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06654193","publication_url":"https://clinicaltrials.gov/study/NCT06654193","title":"Allogeneic Adipose-derived Mesenchymal Stem Cells (MSC) for Acute Kidney Injury After Trauma or Burn","has_exemption":false,"start_date":"2026-02-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Hope Biosciences LLC","sponsor_slug":"hope-biosciences-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07246993","publication_url":"https://clinicaltrials.gov/study/NCT07246993","title":"Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms: A Trial of tDCS and Cognitive Training 3-12 Months Post-mTBI","has_exemption":false,"start_date":"2026-03-05","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216690","publication_url":"https://clinicaltrials.gov/study/NCT07216690","title":"Pregnenolone as a Treatment for Cannabis Intoxication","has_exemption":false,"start_date":"2026-04-24","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325227","publication_url":"https://clinicaltrials.gov/study/NCT07325227","title":"Remimazolam for Sedation in Cataract Surgery, A Phase IV, On-label, Blinded Study","has_exemption":false,"start_date":"2026-04-28","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Fred E, Shapiro","sponsor_slug":"fred-e-shapiro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07313826","publication_url":"https://clinicaltrials.gov/study/NCT07313826","title":"Neurolumen for Chronic Lower Back Pain: A Pilot RCT Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Defense and Veterans Center for Integrative Pain Management","sponsor_slug":"defense-and-veterans-center-for-integrative-pain-management","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07180615","publication_url":"https://clinicaltrials.gov/study/NCT07180615","title":"Neomycine/Metronidazole- vs Rifaximin-based Gut Decolonisation Prior to Colon Surgery: a Randomized Multicenter Trial","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Universität Luzern","sponsor_slug":"universitat-luzern","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513324","publication_url":"https://clinicaltrials.gov/study/NCT07513324","title":"Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07054801","publication_url":"https://clinicaltrials.gov/study/NCT07054801","title":"Intra-arterial Lidocaine and Methylprednisolone Injection Into the Middle Meningeal Artery For Treatment of Headache Associated With Subarachnoid Hemorrhage","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Daniel Raper, MBBS","sponsor_slug":"daniel-raper-mbbs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07459829","publication_url":"https://clinicaltrials.gov/study/NCT07459829","title":"A Phase 2b, Randomized, Double-masked, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of CU06-1004 for 24 Weeks in Patients With Center-Involved Diabetic Macular Edema (DME)","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Curacle Co., Ltd.","sponsor_slug":"curacle-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201987","publication_url":"https://clinicaltrials.gov/study/NCT07201987","title":"Intraoperative Placement of Vancomycin-impregnated Calcium Sulfate Beads Conjugated With Analgesics to Improve Spine Surgery Outcomes","has_exemption":false,"start_date":"2027-01-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Ganesh M. Shankar","sponsor_slug":"ganesh-m-shankar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03867487","publication_url":"https://clinicaltrials.gov/study/NCT03867487","title":"SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease","has_exemption":false,"start_date":"2027-05-01","completion_date":"2028-01-01","has_results":false,"results_due":false,"sponsor_name":"Justin Ryder","sponsor_slug":"justin-ryder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06183268","publication_url":"https://clinicaltrials.gov/study/NCT06183268","title":"Evaluation of Radiobiological Effects in Skin Toxicities for Head and Neck Cancer Patients With Pencil Beam Scanning Proton Therapy","has_exemption":false,"start_date":"2023-12-13","completion_date":"2028-01-02","has_results":false,"results_due":false,"sponsor_name":"Covenant Health Cancer Center","sponsor_slug":"covenant-health-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06207305","publication_url":"https://clinicaltrials.gov/study/NCT06207305","title":"A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma","has_exemption":false,"start_date":"2024-01-30","completion_date":"2028-01-02","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07063212","publication_url":"https://clinicaltrials.gov/study/NCT07063212","title":"A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy","has_exemption":false,"start_date":"2025-07-02","completion_date":"2028-01-02","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07172919","publication_url":"https://clinicaltrials.gov/study/NCT07172919","title":"A Rollover Study of Sotorasib With or Without Panitumumab for the Treatment of Cancer Subjects With KRAS p.G12C Mutation Previously Treated in an Amgen-Sponsored Study","has_exemption":false,"start_date":"2026-01-02","completion_date":"2028-01-02","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619729","publication_url":"https://clinicaltrials.gov/study/NCT07619729","title":"Clinical Study to Evaluate the Efficacy of an Oral Health Behavioral Intervention on Medical and Dental Claims in People With Diabetes","has_exemption":false,"start_date":"2026-05-26","completion_date":"2028-01-02","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03625648","publication_url":"https://clinicaltrials.gov/study/NCT03625648","title":"CSP #2008 - Pentoxifylline in Diabetic Kidney Disease","has_exemption":false,"start_date":"2019-11-18","completion_date":"2028-01-03","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06891417","publication_url":"https://clinicaltrials.gov/study/NCT06891417","title":"A Phase 1/2, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Immunogenicity, and Efficacy of a Chlamydia Trachomatis mRNA Vaccine Candidate in Adults Aged 18 to 29 Years","has_exemption":false,"start_date":"2025-03-27","completion_date":"2028-01-03","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325253","publication_url":"https://clinicaltrials.gov/study/NCT07325253","title":"A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations","has_exemption":false,"start_date":"2025-11-18","completion_date":"2028-01-03","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07575399","publication_url":"https://clinicaltrials.gov/study/NCT07575399","title":"A Phase 3, Open-label Trial to Evaluate the Efficacy, Safety and Tolerability of Switching From the Glucagon-like Peptide-1 Receptor Agonists to Maridebart Cafraglutide in Adult Participants With Obesity or Overweight","has_exemption":false,"start_date":"2026-05-11","completion_date":"2028-01-03","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05733000","publication_url":"https://clinicaltrials.gov/study/NCT05733000","title":"Phase II Open-Label Multi-Cohort Study Evaluating CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Patients With Advanced Chemorefractory Colorectal, Pancreatic, or Other Solid Cancers","has_exemption":false,"start_date":"2023-03-08","completion_date":"2028-01-04","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06659640","publication_url":"https://clinicaltrials.gov/study/NCT06659640","title":"InsigHHT: A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2-part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-6400 in Adult Healthy Volunteers and Multiple Dose ALN-6400 in Adult Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","has_exemption":false,"start_date":"2024-11-07","completion_date":"2028-01-05","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07324070","publication_url":"https://clinicaltrials.gov/study/NCT07324070","title":"New Methods Electroconvulsive Therapy Augmentation","has_exemption":false,"start_date":"2026-01-05","completion_date":"2028-01-05","has_results":false,"results_due":false,"sponsor_name":"Charles University, Czech Republic","sponsor_slug":"charles-university-czech-republic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05797168","publication_url":"https://clinicaltrials.gov/study/NCT05797168","title":"A Modular Phase I/IIa, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors","has_exemption":false,"start_date":"2023-06-05","completion_date":"2028-01-06","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03969004","publication_url":"https://clinicaltrials.gov/study/NCT03969004","title":"A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma","has_exemption":false,"start_date":"2019-06-04","completion_date":"2028-01-07","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06731894","publication_url":"https://clinicaltrials.gov/study/NCT06731894","title":"A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy","has_exemption":false,"start_date":"2025-10-03","completion_date":"2028-01-07","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307431","publication_url":"https://clinicaltrials.gov/study/NCT06307431","title":"A Phase 2, Randomized, Double-blind, Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Participants With Renal Cell Carcinoma (INTerpath-004).","has_exemption":false,"start_date":"2024-04-10","completion_date":"2028-01-08","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04083183","publication_url":"https://clinicaltrials.gov/study/NCT04083183","title":"Targeted Astatine-211-Labeled BC8-B10 Monoclonal Antibody as Reduced Intensity Conditioning for Nonmalignant Diseases","has_exemption":false,"start_date":"2020-06-16","completion_date":"2028-01-09","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07015242","publication_url":"https://clinicaltrials.gov/study/NCT07015242","title":"The CAROLYN Trial: Lisocabtagene Maraleucel as First-Line Therapy for Primary Central Nervous System Lymphoma (PCNSL) in Transplant-Ineligible Patients","has_exemption":false,"start_date":"2025-11-06","completion_date":"2028-01-09","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","sponsor_slug":"juno-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04592445","publication_url":"https://clinicaltrials.gov/study/NCT04592445","title":"Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction: Randomized Controlled Feasibility Trial - The Rebalance HF Study","has_exemption":false,"start_date":"2020-12-18","completion_date":"2028-01-10","has_results":false,"results_due":false,"sponsor_name":"Axon Therapies, Inc.","sponsor_slug":"axon-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06132958","publication_url":"https://clinicaltrials.gov/study/NCT06132958","title":"A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG-3095)","has_exemption":false,"start_date":"2023-12-06","completion_date":"2028-01-10","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223568","publication_url":"https://clinicaltrials.gov/study/NCT06223568","title":"Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer","has_exemption":false,"start_date":"2024-06-10","completion_date":"2028-01-10","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311721","publication_url":"https://clinicaltrials.gov/study/NCT06311721","title":"A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-09-09","completion_date":"2028-01-10","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07630064","publication_url":"https://clinicaltrials.gov/study/NCT07630064","title":"Flo Digital Contraceptive Study: Safety and Effectiveness of Flo's Personalized Fertility Awareness Tool for Preventing Pregnancy","has_exemption":false,"start_date":"2026-04-22","completion_date":"2028-01-10","has_results":false,"results_due":false,"sponsor_name":"Flo Health Inc.","sponsor_slug":"flo-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07196748","publication_url":"https://clinicaltrials.gov/study/NCT07196748","title":"A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults With an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2025-10-01","completion_date":"2028-01-14","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03476681","publication_url":"https://clinicaltrials.gov/study/NCT03476681","title":"Phase 1/2 With Expansion Cohorts in a Study of NEO-201 in Adults With Chemo-Resistant Solid Tumors","has_exemption":false,"start_date":"2019-01-18","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"Precision Biologics, Inc","sponsor_slug":"precision-biologics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05668351","publication_url":"https://clinicaltrials.gov/study/NCT05668351","title":"Phase II Trial of Sparing the Urethra, Pudendal Artery and Rectum During Stereotactic Ablative Body Radiotherapy (SUPR-SABR) for Low and Intermediate Risk Prostate Cancer","has_exemption":false,"start_date":"2023-05-12","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06043674","publication_url":"https://clinicaltrials.gov/study/NCT06043674","title":"A Phase 2 Study of Glofitamab as Monotherapy or in Combination With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation","has_exemption":false,"start_date":"2024-01-22","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"Christine Ryan","sponsor_slug":"christine-ryan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06194929","publication_url":"https://clinicaltrials.gov/study/NCT06194929","title":"Phase 1b/2 Trial of Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma","has_exemption":false,"start_date":"2024-03-20","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961071","publication_url":"https://clinicaltrials.gov/study/NCT06961071","title":"Parathyroid Allotransplant for Treatment of Hypoparathyroidism: PATTH","has_exemption":false,"start_date":"2026-01-15","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"Peter Stock","sponsor_slug":"peter-stock","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357389","publication_url":"https://clinicaltrials.gov/study/NCT07357389","title":"VR for ICU Delirium Prevention","has_exemption":false,"start_date":"2026-03-10","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07458087","publication_url":"https://clinicaltrials.gov/study/NCT07458087","title":"Feasibility and Accuracy of the Accuro 3S","has_exemption":false,"start_date":"2026-07-15","completion_date":"2028-01-15","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03921008","publication_url":"https://clinicaltrials.gov/study/NCT03921008","title":"Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma","has_exemption":false,"start_date":"2019-05-21","completion_date":"2028-01-16","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609005","publication_url":"https://clinicaltrials.gov/study/NCT06609005","title":"A Phase 1 and Phase 2, Multi-Center, Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Evidence of Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2025-01-23","completion_date":"2028-01-17","has_results":false,"results_due":false,"sponsor_name":"Shenzhen Ionova Life Sciences Co., Ltd.","sponsor_slug":"shenzhen-ionova-life-sciences-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079735","publication_url":"https://clinicaltrials.gov/study/NCT07079735","title":"VALganciclovir vs. LETermovir for Primary Prevention of CMV in Moderate to High-Risk Heart Transplant Recipients (The VALET-CMV Study)","has_exemption":false,"start_date":"2025-09-12","completion_date":"2028-01-17","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06989437","publication_url":"https://clinicaltrials.gov/study/NCT06989437","title":"A Phase 2b/3, Randomized, Double-Blind Study to Investigate the Efficacy, Safety, and Tolerability of Ponsegromab (PF-06946860) Compared With Placebo Both With Background First-Line Chemotherapy in Adult Participants With Cachexia and Metastatic Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2025-10-03","completion_date":"2028-01-17","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05038150","publication_url":"https://clinicaltrials.gov/study/NCT05038150","title":"Phase I/IIa, Open-label Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Modified Salmonella Typhimurium SGN1 in Patients With Advanced Solid Tumor","has_exemption":false,"start_date":"2023-01-16","completion_date":"2028-01-18","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Sinogen Pharmaceutical Co., Ltd","sponsor_slug":"guangzhou-sinogen-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06940518","publication_url":"https://clinicaltrials.gov/study/NCT06940518","title":"Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma","has_exemption":false,"start_date":"2025-07-02","completion_date":"2028-01-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05775718","publication_url":"https://clinicaltrials.gov/study/NCT05775718","title":"Safety and Immunogenicity of Shingrix Administered to Recipients of Allogeneic Peripheral and Cord Blood Stem Cell Transplants: Effect of Timing of Vaccination After Transplantation","has_exemption":false,"start_date":"2023-10-24","completion_date":"2028-01-20","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798324","publication_url":"https://clinicaltrials.gov/study/NCT06798324","title":"Using Non-Invasive Brain Stimulation (tDCS) as an Adjunct to Varenicline for the Treatment of Tobacco Dependence: a Randomized Controlled Trial","has_exemption":false,"start_date":"2025-03-10","completion_date":"2028-01-20","has_results":false,"results_due":false,"sponsor_name":"Centre for Addiction and Mental Health","sponsor_slug":"centre-for-addiction-and-mental-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06831136","publication_url":"https://clinicaltrials.gov/study/NCT06831136","title":"Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma; a Phase II Trial PANcreas CAncer RaDIofrequeNcy AbLation","has_exemption":false,"start_date":"2025-03-26","completion_date":"2028-01-20","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07355296","publication_url":"https://clinicaltrials.gov/study/NCT07355296","title":"PODOMOUNT-Basket, a Phase II, Multicentre, Randomised, 2-arm Parallel-group, Double-blind, Placebo-controlled Basket Trial to Assess Safety, Tolerability, PK, and Efficacy of BI 764198 in Four Proteinuric Kidney Diseases","has_exemption":false,"start_date":"2026-03-23","completion_date":"2028-01-20","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06421636","publication_url":"https://clinicaltrials.gov/study/NCT06421636","title":"A PHASE 2, TWO-PART, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF SUBCUTANEOUSLY ADMINISTERED REGN7999 (AN INHIBITOR OF TMPRSS6) IN PARTICIPANTS WITH IRON OVERLOAD DUE TO NON-TRANSFUSION DEPENDENT β-THALASSEMIA","has_exemption":false,"start_date":"2024-09-30","completion_date":"2028-01-24","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793166","publication_url":"https://clinicaltrials.gov/study/NCT03793166","title":"PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]","has_exemption":false,"start_date":"2019-06-07","completion_date":"2028-01-25","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054555","publication_url":"https://clinicaltrials.gov/study/NCT06054555","title":"A Randomized, Double-Blind Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Treatment-Naïve Unresectable or Metastatic Melanoma","has_exemption":false,"start_date":"2023-11-02","completion_date":"2028-01-25","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170788","publication_url":"https://clinicaltrials.gov/study/NCT06170788","title":"A Randomized, Open-label, Phase 3 Study of MK-2870 in Combination With Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS Greater Than or Equal to 50% (TroFuse-007)","has_exemption":false,"start_date":"2023-12-15","completion_date":"2028-01-25","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07199361","publication_url":"https://clinicaltrials.gov/study/NCT07199361","title":"Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation","has_exemption":false,"start_date":"2025-03-24","completion_date":"2028-01-25","has_results":false,"results_due":false,"sponsor_name":"Florida International University","sponsor_slug":"florida-international-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05557591","publication_url":"https://clinicaltrials.gov/study/NCT05557591","title":"A Phase 2 Study of Cemiplimab (Anti-PD-1 Antibody) in Combination With BNT116 (FixVac Lung) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%","has_exemption":false,"start_date":"2023-04-21","completion_date":"2028-01-26","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06906211","publication_url":"https://clinicaltrials.gov/study/NCT06906211","title":"Low Intensity Focused Ultrasound for Chronic Pain: High Resolution Targeting of The Human Insula","has_exemption":false,"start_date":"2025-01-15","completion_date":"2028-01-26","has_results":false,"results_due":false,"sponsor_name":"Washington D.C. Veterans Affairs Medical Center","sponsor_slug":"washington-dc-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226882","publication_url":"https://clinicaltrials.gov/study/NCT07226882","title":"A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF DIFFERENT VACCINATION SCHEDULES OF 6-VALENT OSPA-BASED LYME DISEASE VACCINE, VLA15, IN HEALTHY ADULT PARTICIPANTS","has_exemption":false,"start_date":"2025-11-19","completion_date":"2028-01-27","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03670966","publication_url":"https://clinicaltrials.gov/study/NCT03670966","title":"A Phase I/II Study Evaluating Escalating Doses of 211At-Labeled Anti-CD45 MAb BC8-B10 (211At-BC8-B10) Followed by Related Haplo-Identical Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Leukemia or Myelodysplastic Syndrome (MDS)","has_exemption":true,"start_date":"2019-07-10","completion_date":"2028-01-28","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04471727","publication_url":"https://clinicaltrials.gov/study/NCT04471727","title":"A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN328 Monotherapy and HPN328 With Atezolizumab or Ifinatamab Deruxtecan (I-DXd) in Patients With Advanced Cancers Associated With Expression of Delta-like Canonical Notch Ligand 3 (DLL3).","has_exemption":false,"start_date":"2020-12-14","completion_date":"2028-01-28","has_results":false,"results_due":false,"sponsor_name":"Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","sponsor_slug":"harpoon-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05734066","publication_url":"https://clinicaltrials.gov/study/NCT05734066","title":"A Phase 1/2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Recommended Phase 2 Dose (RP2D), and Efficacy of Lurbinectedin Monotherapy in Pediatric Participants With Previously Treated Solid Tumors Followed by Expansion to Assess Efficacy and Safety in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma.","has_exemption":false,"start_date":"2023-05-23","completion_date":"2028-01-28","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05902169","publication_url":"https://clinicaltrials.gov/study/NCT05902169","title":"A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Glioblastoma.","has_exemption":false,"start_date":"2024-01-29","completion_date":"2028-01-28","has_results":false,"results_due":false,"sponsor_name":"CarThera","sponsor_slug":"carthera","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06544291","publication_url":"https://clinicaltrials.gov/study/NCT06544291","title":"Combination of THC and CBD as Novel Treatment for Co-Occurring Opioid Use Disorder and Chronic Pain","has_exemption":false,"start_date":"2024-10-22","completion_date":"2028-01-28","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07438405","publication_url":"https://clinicaltrials.gov/study/NCT07438405","title":"An Open-label, Rollover Study for Participants With Thyroid Eye Disease Previously Enrolled in Amgen-sponsored AMG 732 Studies and Are Primary Proptosis Non-responders or Who Relapsed During the Safety Follow-up","has_exemption":false,"start_date":"2026-05-07","completion_date":"2028-01-29","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04092192","publication_url":"https://clinicaltrials.gov/study/NCT04092192","title":"Prospective Comparison of Rigid Forceps Versus Endovascular Snare for Routine IVC Filter Retrieval","has_exemption":false,"start_date":"2018-12-26","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05010122","publication_url":"https://clinicaltrials.gov/study/NCT05010122","title":"A Phase I/II Study of ASTX727, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation","has_exemption":false,"start_date":"2021-07-08","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05470504","publication_url":"https://clinicaltrials.gov/study/NCT05470504","title":"Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance","has_exemption":false,"start_date":"2023-01-23","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06138977","publication_url":"https://clinicaltrials.gov/study/NCT06138977","title":"Controlling Locomotion Over Continuously Varying Activities for Agile Powered Prosthetic Legs","has_exemption":false,"start_date":"2023-12-06","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06564142","publication_url":"https://clinicaltrials.gov/study/NCT06564142","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)","has_exemption":false,"start_date":"2024-08-30","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"Alpine Immune Sciences Inc, A Subsidiary of Vertex","sponsor_slug":"alpine-immune-sciences-inc-a-subsidiary-of-vertex","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05421858","publication_url":"https://clinicaltrials.gov/study/NCT05421858","title":"An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participants With Candidemia and/or Invasive Candidiasis","has_exemption":false,"start_date":"2024-12-11","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"Basilea Pharmaceutica","sponsor_slug":"basilea-pharmaceutica","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04465500","publication_url":"https://clinicaltrials.gov/study/NCT04465500","title":"Prospective Trial of Combination External Beam Radiation Therapy and MRI-guided, Dose-differentiated High Dose-rate Prostate Brachytherapy Boost for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer","has_exemption":false,"start_date":"2025-01-30","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06294548","publication_url":"https://clinicaltrials.gov/study/NCT06294548","title":"A Phase Ib/II, Dose Escalation and Dose Expansion Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma (HCC)","has_exemption":false,"start_date":"2025-07-29","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05393466","publication_url":"https://clinicaltrials.gov/study/NCT05393466","title":"A Phase I/II, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2028-01-30","has_results":false,"results_due":false,"sponsor_name":"Xcovery Holdings, Inc.","sponsor_slug":"xcovery-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00900575","publication_url":"https://clinicaltrials.gov/study/NCT00900575","title":"Cervical Cancer Detection Using Optical Spectroscopy","has_exemption":false,"start_date":"2006-05-31","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01217931","publication_url":"https://clinicaltrials.gov/study/NCT01217931","title":"Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial","has_exemption":false,"start_date":"2011-01-19","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01352520","publication_url":"https://clinicaltrials.gov/study/NCT01352520","title":"Phase II Trial of Brentuximab Vedotin (SGN-35) at Dose of 1.8 mg/kg IV Every 3 Weeks in Patients With CD30-positive Lymphoproliferative Disorders (Cutaneous Anaplastic Large T-cell Lymphoma (ALCL), Mycosis Fungoides, and Extensive Lymphomatoid Papulosis (LyP)","has_exemption":false,"start_date":"2011-06-30","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02229968","publication_url":"https://clinicaltrials.gov/study/NCT02229968","title":"Efficacy of ε-Aminocaproic Acid (EACA) in Children Undergoing Craniofacial Reconstruction Surgery","has_exemption":false,"start_date":"2014-10-31","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"Children's National Research Institute","sponsor_slug":"childrens-national-research-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02140255","publication_url":"https://clinicaltrials.gov/study/NCT02140255","title":"Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study","has_exemption":false,"start_date":"2015-01-23","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02649959","publication_url":"https://clinicaltrials.gov/study/NCT02649959","title":"An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin","has_exemption":false,"start_date":"2015-10-31","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"Curemark","sponsor_slug":"curemark","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02525757","publication_url":"https://clinicaltrials.gov/study/NCT02525757","title":"DETERRED: PD-L1 blockadE To Evaluate the Safety of Lung CanceR Therapy Using Carboplatin, Paclitaxel, and Radiation CombinEd With MPDL3280A","has_exemption":false,"start_date":"2016-01-26","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02570984","publication_url":"https://clinicaltrials.gov/study/NCT02570984","title":"Controlling and Preventing Asthma Progression and Severity in Kids","has_exemption":false,"start_date":"2018-11-27","completion_date":"2028-01-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null}]}